Aaron Tachibana Buys Shares of Personalis, Inc. (PSNL)
CFO and COO Aaron Tachibana acquired 51,251 shares of Personalis, Inc. at $7.48 each.
Key Points
- On June 26, 2026, Aaron Tachibana, CFO and COO of Personalis, Inc., purchased 51,251 shares at an average price of $7.48, totaling $383,367.
- Personalis, Inc. has a market cap of approximately $1.36 billion and a 52-week trading range between $3.84 and $13.37.
- Analysts from BTIG and Needham maintain a 'buy' rating, with price targets up to $13.00.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Aaron Tachibana, the CFO and COO of Personalis, Inc., recently bought 51,251 shares of the company at an average price of $7.48 each. This purchase, made on June 26, 2026, is valued at about $383,367. Tachibana's acquisition was not part of a pre-planned trading program.
Insider Buying and Selling at Personalis, Inc.
Alongside Tachibana's purchase, other notable insider activities occurred on the same day. Christopher Hall, the CEO of Personalis, also bought 100,000 shares at $1.61 each. Both Hall and Tachibana later sold shares at higher prices under planned sales, with Hall selling at $13.15 and Tachibana at $13.18. These transactions highlight a mix of strategic buys and planned sales by the company's top executives.
Personalis, Inc. Stock Down 23.7%
Shares of Personalis, Inc. (NasdaqGM: PSNL) traded near $13.02 as of Saturday. The company has a market capitalization of about $1.36 billion. It operates with a beta of 2.276, indicating higher volatility compared to the market. The stock has experienced a 52-week low of $3.84 and a high of $13.37. The company's current ratio is 6.613, and it maintains a quick ratio of 6.307, reflecting strong liquidity.
$PSNL stock price
Daily closing prices, year to date. Not investment advice.
Analysts Set New Price Targets
Analysts have been active in maintaining their ratings for Personalis, Inc. BTIG and Needham both reiterated their 'buy' ratings, with price targets reaching up to $13.00. On May 12, 2026, Morgan Stanley maintained a 'hold' rating with a target of $9.00. The consensus among analysts remains cautiously optimistic, with an average target price of $10.86 based on seven opinions.
About Personalis, Inc.
Personalis, Inc. develops and sells advanced cancer genomic tests and services both in the U.S. and internationally. Its products include NeXT Personal and ImmunoID NeXT, which are used for cancer detection and monitoring. The company, headquartered in Fremont, California, was founded in 2011 and is led by CEO Christopher M. Hall. It employs 259 people and collaborates with entities like Tempus AI to enhance cancer testing.
Bottom Line
Aaron Tachibana's recent purchase of Personalis shares underscores his confidence in the company's prospects. Investors often track insider transactions like these as potential indicators of a company's future performance. However, it's important to remember that these filings are backward-looking and may not reflect the current position of the insiders.
Get Personalis, Inc. alerts
New 13F filings, insider trades, and analyst moves on $PSNL, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.